Eye Twitching and Qelbree
Eye twitching is not a documented adverse effect of Qelbree (viloxazine) based on FDA labeling and clinical trial data. The FDA-approved prescribing information does not list eye twitching, blepharospasm, or any ocular movement disorders among the adverse reactions observed in clinical trials 1.
What the Evidence Shows
The most comprehensive safety data comes from:
- Short-term trials: Over 1,019 pediatric patients and 189 adult patients were exposed to Qelbree in controlled studies 1
- Long-term data: 1,100 participants (646 children, 454 adolescents) followed for up to 72 months in an open-label extension trial 2
Most Common Adverse Effects Actually Reported
The adverse events occurring in ≥5% of patients across all trials were 1, 2:
- Somnolence/sedation (9.5%)
- Headache (8.9%)
- Nasopharyngitis (9.7%)
- Decreased appetite (6.0%)
- Fatigue (5.7%)
- Nausea
- Insomnia
- Irritability
Eye twitching does not appear on this list or anywhere in the comprehensive FDA safety documentation.
Clinical Reasoning
Given Qelbree's mechanism as a serotonin-norepinephrine modulating agent with moderate norepinephrine transporter inhibition 3, 4, there is no pharmacological basis to expect ocular motor side effects. The drug lacks the anticholinergic properties that might theoretically affect eye movements 5.
Important Caveats
If a patient on Qelbree develops eye twitching, consider:
- Coincidental timing: Eye twitching (benign fasciculations) is extremely common in the general population and often related to stress, fatigue, or caffeine
- ADHD-related: Motor tics can be part of ADHD or comorbid conditions
- Other medications: Check for concomitant medications, particularly stimulants if combined therapy is being used
- Fatigue/somnolence: Since Qelbree causes somnolence in ~10% of patients 2, secondary eye strain or fatigue could theoretically manifest as twitching
The absence of eye twitching in extensive clinical trial data spanning thousands of patients over multiple years strongly suggests this is not a medication-related effect 1, 2.